These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 15525721

  • 1. Mass treatment with single-dose azithromycin for trachoma.
    Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC.
    N Engl J Med; 2004 Nov 04; 351(19):1962-71. PubMed ID: 15525721
    [Abstract] [Full Text] [Related]

  • 2. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK, Munoz B, Mkocha H, Gaydos C, Quinn T.
    Invest Ophthalmol Vis Sci; 2007 Apr 04; 48(4):1492-7. PubMed ID: 17389476
    [Abstract] [Full Text] [Related]

  • 3. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.
    West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL, Mabey DC.
    Lancet; 2005 Oct 08; 366(9493):1296-300. PubMed ID: 16214600
    [Abstract] [Full Text] [Related]

  • 4. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
    Bailey RL, Arullendran P, Whittle HC, Mabey DC.
    Lancet; 1993 Aug 21; 342(8869):453-6. PubMed ID: 8102427
    [Abstract] [Full Text] [Related]

  • 5. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
    Ramadhani AM, Derrick T, Macleod D, Massae P, Malisa A, Mbuya K, Mtuy T, Makupa W, Roberts CH, Bailey RL, Mabey DCW, Holland MJ, Burton MJ.
    PLoS Negl Trop Dis; 2019 Jul 21; 13(7):e0007559. PubMed ID: 31306419
    [Abstract] [Full Text] [Related]

  • 6. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.
    Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, Sillah A, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL.
    Lancet; 2019 Jul 21; 365(9467):1321-8. PubMed ID: 15823382
    [Abstract] [Full Text] [Related]

  • 7. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
    Harding-Esch EM, Holland MJ, Schémann JF, Sillah A, Sarr B, Christerson L, Pickering H, Molina-Gonzalez S, Sarr I, Andreasen AA, Jeffries D, Grundy C, Mabey DCW, Herrmann B, Bailey RL.
    Parasit Vectors; 2019 Oct 22; 12(1):497. PubMed ID: 31640755
    [Abstract] [Full Text] [Related]

  • 8. Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania.
    Campbell JP, Mkocha H, Munoz B, West SK.
    Ophthalmic Epidemiol; 2012 Feb 22; 19(1):38-42. PubMed ID: 22273357
    [Abstract] [Full Text] [Related]

  • 9. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
    Last AR, Burr SE, Harding-Esch E, Cassama E, Nabicassa M, Roberts CH, Mabey DCW, Holland MJ, Bailey RL.
    Parasit Vectors; 2017 Dec 28; 10(1):624. PubMed ID: 29282126
    [Abstract] [Full Text] [Related]

  • 10. Antibiotics for trachoma.
    Evans JR, Solomon AW.
    Cochrane Database Syst Rev; 2011 Mar 16; (3):CD001860. PubMed ID: 21412875
    [Abstract] [Full Text] [Related]

  • 11. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
    West SK, Munoz B, Mkocha H, Gaydos CA, Quinn TC.
    J Infect Dis; 2011 Jul 15; 204(2):268-73. PubMed ID: 21673038
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
    Wilson N, Goodhew B, Mkocha H, Joseph K, Bandea C, Black C, Igietseme J, Munoz B, West SK, Lammie P, Kasubi M, Martin DL.
    Ophthalmic Epidemiol; 2019 Feb 15; 26(1):1-6. PubMed ID: 30543311
    [Abstract] [Full Text] [Related]

  • 13. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ, Porco TC, Hong KC, Lee DC, Alemayehu W, Melese M, Lakew T, Yi E, House J, Chidambaram JD, Whitcher JP, Gaynor BD, Lietman TM.
    BMC Infect Dis; 2007 Aug 07; 7():91. PubMed ID: 17683646
    [Abstract] [Full Text] [Related]

  • 14. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
    Gebre T, Ayele B, Zerihun M, Genet A, Stoller NE, Zhou Z, House JI, Yu SN, Ray KJ, Emerson PM, Keenan JD, Porco TC, Lietman TM, Gaynor BD.
    Lancet; 2012 Jan 14; 379(9811):143-51. PubMed ID: 22192488
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania.
    Broman AT, Shum K, Munoz B, Duncan DD, West SK.
    Invest Ophthalmol Vis Sci; 2006 Jan 14; 47(1):99-104. PubMed ID: 16384950
    [Abstract] [Full Text] [Related]

  • 20. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
    West SK, Moncada J, Munoz B, Mkocha H, Storey P, Hardick J, Gaydos CA, Quinn TC, Schachter J.
    J Infect Dis; 2014 Jul 01; 210(1):65-71. PubMed ID: 24446528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.